We are developing cutting-edge in vivo optical molecular imaging techniques that operates either in absorption, fluorescence or bioluminescence mode or in combination of those. Our ultimate goal is to translate these technique to clinical settings. These techniques mostly utilize true multi-modality imaging (MMI) approach and focus on both preclinical and clinical applications.